This is a working overview of Ac-LKKTETQ, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-06. Anything still debated is marked as such rather than presented as settled.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
Once in solution, short peptides are generally less stable than the dry powder, and repeated freeze-thaw cycles are a common cause of loss. Laboratory guidance usually calls for aliquoting on first dissolution and storing aliquots at -20 °C or below, away from light. Adsorption to plastic and glass surfaces can lower measured concentration, particularly at low concentrations, so container material and buffer choice can affect results. Visible cloudiness, colour change or unexpected precipitate is a signal to re-check the material.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 0.9 kDa | Depends on exact fragment sequence and counterion |
| Amino acid sequence | LKKTETQ (commonly cited) | Short actin-binding motif from thymosin beta-4 |
| Common salt form | Acetate salt | Trifluoroacetate also reported in research material |
| Reconstitution solvent | Sterile water or buffer | Gentle mixing; avoid vigorous agitation |
| Solution storage | -20 °C or lower | Aliquot to avoid repeated freeze-thaw cycles |
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
The oral bioavailability of amphetamine varies with gastrointestinal pH; it is well absorbed from the gut, and bioavailability is typically 90%. Amphetamine is a weak base with a pKa of 9.9; consequently, when the pH is basic, more of the drug is in its lipid soluble free base form, and more is absorbed through the lipid-rich cell membranes of the gut epithelium. Conversely, an acidic pH means the drug is predominantly in a water-soluble cationic (salt) form, and less is absorbed. Between 16-20% of amphetamine circulating in the bloodstream is bound to plasma proteins. Following absorption, amphetamine readily distributes into most tissues in the body, with high concentrations occurring in cerebrospinal fluid and brain tissue. The half-lives of amphetamine enantiomers differ and vary with urine pH. At normal urine pH, the half-lives of dextroamphetamine and levoamphetamine are 9–11 hours and 11–14 hours, respectively. Highly acidic urine will reduce the enantiomer half-lives to 7 hours; highly alkaline urine will increase the half-lives up to 34 hours. The immediate-release and extended release variants of salts of both isomers reach peak plasma concentrations at 3 hours and 7 hours post-dose respectively. Amphetamine is eliminated via the kidneys, with 30–40% of the drug being excreted unchanged at normal urinary pH. When the urinary pH is basic, amphetamine is in its free base form, so less is excreted.
With their large fore-flippers, eared seals are usually able to prevent the first bite from being secure, but are still weakened and vulnerable to being recaptured. Prey is released after it dies of blood loss, and the shark feeds on the carcass after it floats to the surface. In 1984, Timothy Tricas and John McCosker suggested that white sharks bite seals, release them, and then wait for them to bleed to death before eating based on observations at Dangerous Reef, South Australia. Others have found no evidence for this hypothesis, but the strategy is possibly employed on bull elephant seals. Off South Africa, ambushes on Cape fur seals usually involve the shark leaping or breaching out of the water. To breach, a shark starts at around 20 m (66 ft) below the surface and ascends quickly towards its target while tilting its body vertically. Sharks may breach partially or entirely out of the water at different angles, clearing up to around 3 m (10 ft) when airborne. Missed seals may be chased after; such pursuits involve the prey using its speed and agility to escape as the shark employs various maneuvers to catch them. The longer the chase, the less likely the shark is to succeed. Sharks commonly consume fur seals quickly after they are killed. White sharks in Cape Cod hunt seals in shallow water, relying on the murkiness of the water for concealment and striking them from the sides.
Protective clothing is designed to protect operators in the event of a moving chain touching their clothing by snarling the chain and sprocket, by using special synthetic fibers woven into the garment. Despite safety features and protective clothing, injuries can still occur, due to the large forces involved in the work from the fast-moving, sharp chain, or the vibration and noise of the machinery. A common accident arises from "kickback" when a chain tooth at the tip of the guide bar catches on wood without cutting through it. This throws the bar (with its moving chain) in an upward arc toward the operator, which can cause serious injury or even death. A dangerous situation occurs when heavy timber begins to fall or move before a cut is complete. The chainsaw operator may be trapped or crushed. Similarly, timber falling in an unplanned direction may harm the operator or other workers, or an operator working at a height may fall or be injured by falling timber. Like other hand-held machinery, the operation of chainsaws can cause vibration white finger, tinnitus, or industrial deafness. These symptoms were very common before vibration damping using rubber or steel springs were introduced. Heated handles are additional help. Newer, lighter, and easier to wield cordless electric chainsaws use brushless motors, which further decrease noise and vibration compared to traditional petroleum-powered models. The risks associated with chainsaw use mean that protective clothing like chainsaw boots, chaps, and hearing protectors are normally worn while cutting.
Sources: en.wikipedia.org
=== Purpose === There are two major applications to studying the genome at the single-cell level. One application is to track the changes that occur in bacterial populations, where phenotypic differences are often seen. These differences are easily missed by bulk sequencing of a population, but can be observed in single-cell sequencing. The second major application is to study the genetic evolution of cancer. Since cancer cells are constantly mutating it is of great interest to researchers to see how cancers evolve at the level of individual cells. These patterns of somatic mutations and copy number aberration can be observed using single-cell sequencing.
Automatic defrosting A power failure warning that alerts the user by flashing a temperature display. It may display the maximum temperature reached during the power failure, and whether frozen food has defrosted or may contain harmful bacteria. Chilled water and ice from a dispenser in the door. Water and ice dispensing became available in the 1970s. In some refrigerators, the process of making ice is built-in so the user doesn't have to manually use ice trays. Some refrigerators have water chillers and water filtration systems. Cabinet rollers that lets the refrigerator roll out for easier cleaning Adjustable shelves and trays A status indicator that notifies when it is time to change the water filter An in-door ice caddy, which relocates the ice-maker storage to the freezer door and saves approximately 60 litres (2.1 cu ft) of usable freezer space. It is also removable, and helps to prevent ice-maker clogging. A cooling zone in the refrigerator door shelves. Air from the freezer section is diverted to the refrigerator door, to cool milk or juice stored in the door shelf. A drop down door built into the refrigerator main door, giving easy access to frequently used items such as milk, thus saving energy by not having to open the main door. A Fast Freeze function to rapidly cool foods by running the compressor for a predetermined amount of time and thus temporarily lowering the freezer temperature below normal operating levels. It is recommended to use this feature several hours before adding more than 1 kg of unfrozen food to the freezer.
== Colombia == In the late 1980s, major narcotics trafficking and terrorist problems within the region covered by the Southern Command (USSOUTHCOM) worsened. USSOUTHCOM was (and remains) responsible for all of South America, Central America, and the Caribbean (CARIBCOM). The 7th Special Forces Group deployed detachments, trainers and advisers in conjunction with teams from the 1st Psychological Operations Battalion to assist Host Nation (HN) forces. During the late 1990s, 7 SFG(A) also deployed to Colombia and trained three Counter Narcotics Battalions and assisted in the establishment of a Brigade Headquarters. These were the first units of their kind in Colombia and each is known as "Batallón Contra Narcotraficantes" or BACNA. These elements continue to be very successful against the narcotics industry which thrives in Colombia. U.S. Army Special Forces detachments still rotate among various locations within Colombia, training HN units in counter-guerrilla and counter-narcotics roles, and SF detachments routinely deploy to other countries within the USSOUTHCOM area of responsibility.
In 1887, a laboratory for the study of bacteria, the Hygienic Laboratory, was established within the Marine Hospital Service, which at the time was expanding its functions beyond the system of Marine Hospitals into quarantine and research programs. It was initially located at the New York Marine Hospital on Staten Island. In 1891, it moved to the top floor of the Butler Building in Washington, D.C. In 1904, it moved again to a new campus at the Old Naval Observatory, which grew to include five major buildings. In 1901, the Division of Scientific Research was formed, which included the Hygienic Laboratory as well as other research offices of the Marine Hospital Service. In 1912, the Marine Hospital Service became the Public Health Service (PHS). In 1922, PHS established a Special Cancer Investigations laboratory at Harvard Medical School. This development marked the beginning of partnerships with universities. In 1930, the Hygienic Laboratory was re-designated as the National Institute of Health by the Ransdell Act, and was given $750,000 to construct two NIH buildings at the Old Naval Observatory campus. In 1937, the NIH absorbed the rest of the Division of Scientific Research, of which it was formerly part. In 1938, the NIH moved to its current campus in Bethesda, Maryland. Over the next few decades, Congress would markedly increase funding of the NIH. Various institutes and centers within the NIH were created for specific research programs. In 1944, the Public Health Service Act was approved and the National Cancer Institute became a division of the NIH.
Sources: en.wikipedia.org
Periungual angiofibromas are also termed Koenen's tumors, periungual fibromas, and subungual fibromas. In addition, these tumors were formerly regarded as a type of acral angiofibroma (see below description). These lesions present as multiple nodules or tumors under multiple finger and/or toe nails of individuals with tuberous sclerosis or in one case the Birt-Hogg-Dube syndrome. Periungual angiofibromas have also been reported to occur in individuals that do not have these genetic diseases. Periungual angiofibromas tumors can be highly mutilating finger/toe-nail lesions.
In contrast with EOD, the incidence of LOD has remained unchanged at 0.24-0.26 per 1000 live births in the US. S. agalactiae neonatal meningitis does not present with the hallmark sign of adult meningitis, a stiff neck; rather, it presents with nonspecific symptoms, such as fever, vomiting, and irritability, and can consequently lead to a late diagnosis.
Teresa is portrayed by Chie Tanaka (田中 千絵, Tanaka Chie). Falufian Yaako (ファルファ星人ヤーコ, Farufa Seijin Yāko): A small pig-themed alien child from Planet Faluf who is capable of manipulating locks. Due to this, she was kidnapped by an Alienizer named Gyanjava, who killed her parents and forced her to aid him in bank robberies across the galaxy. Amidst Gyanjava's attempt to access the Deka Base's systems, Yaako escaped from him and came to S.P.D. to stop him. While under Ban's protection, she transforms into her winged-adult form before using her powers to remove Gyanjava's armor so Ban can delete him. Following this, Yaako continues to help S.P.D. Yaako is voiced by Shoko Nakagawa (中川 翔子, Nakagawa Shōko), who also portrays her adult form. Miwa Tomasu (戸増 美和, Tomasu Miwa): Hoji's younger sister who also blurts out English phrases when she gets upset. Miwa Tomasu is portrayed by Kaori Ikeda (池田 香織, Ikeda Kaori). Space Life Form Browgoul (宇宙生物ブラウゴール, Uchū Seibutsu Buraugōru): Monstrous alien beasts that feed on the metal of meteors to increase in size. An Alienizer named Nikaradar brings two of the beasts to Earth, where he feeds on the corpse of a professor he killed whose form he assumes in order to direct a meteor to Earth. Though the first Browgoul is killed by Super Dekaranger Robo, its power is transferred to its recently hatched younger sibling, who overpowers Super Dekaranger Robo before willing the meteor back on its course to Earth. With Nikaradar having been deleted, Abrella intends to breed the second Browgoul himself, following Earth's destruction.
Sources: en.wikipedia.org
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.
Reversed-phase liquid chromatography separates components and reports purity from peak area. Mass spectrometry confirms the molecular mass expected for the sequence. Additional approaches such as peptide mapping or amino acid analysis provide independent confirmation.
Reported percentages depend on the analytical method, the detection wavelength, and whether salts and water are counted. A value above ninety-five percent by chromatography does not by itself establish a correct sequence. Different suppliers also calculate purity against different reference standards.
Sealed, desiccated and protected from light, at -20 °C or lower for long-term storage. Short-term storage at refrigerator temperature is common in working laboratories.